Literature DB >> 15050888

Perspectives on glucocorticoid-induced osteoporosis.

Ernesto Canalis1, John P Bilezikian, Alberto Angeli, Andrea Giustina.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15050888     DOI： 10.1016/j.bone.2003.11.026

Source DB:  PubMed          Journal:  Bone        ISSN： 1873-2763            Impact factor:   4.398


× No keyword cloud information.
  71 in total

1.  Bone turnover markers, BMD and TBS after short-term, high-dose glucocorticoid therapy in patients with Graves' orbitopathy: a small prospective pilot study.

Authors:  S Censi; J Manso; G Pandolfo; G Franceschet; E Cavedon; Y H Zhu; S Carducci; W Gomiero; M Plebani; M Zaninotto; S Watutantrige-Fernando; C Mian; V Camozzi
Journal:  J Endocrinol Invest       Date:  2018-12-05       Impact factor: 4.256

2.  Implications of combined ovariectomy and glucocorticoid (dexamethasone) treatment on mineral, microarchitectural, biomechanical and matrix properties of rat bone.

Authors:  Parameswari Govindarajan; Thaqif Khassawna; Marian Kampschulte; Wolfgang Böcker; Britta Huerter; Lutz Dürselen; Miriam Faulenbach; Christian Heiss
Journal:  Int J Exp Pathol       Date:  2013-09-02       Impact factor: 1.925

Review 3.  Mechanisms of glucocorticoid action in bone.

Authors:  Ernesto Canalis
Journal:  Curr Osteoporos Rep       Date:  2005-09       Impact factor: 5.096

Review 4.  Nothing but skin and bone.

Authors:  F Patrick Ross; Angela M Christiano
Journal:  J Clin Invest       Date:  2006-05       Impact factor: 14.808

5.  Recommendations for the registration of agents for prevention and treatment of glucocorticoid-induced osteoporosis: an update from the Group for the Respect of Ethics and Excellence in Science.

Authors:  J Compston; D M Reid; J Boisdron; M-L Brandi; N Burlet; D Cahall; P D Delmas; W Dere; J-P Devogelaer; L A Fitzpatrick; B Flamion; N Goel; S Korte; A Laslop; B Mitlak; S Ormarsdottir; J Ringe; R Rizzoli; Y Tsouderos; T Van Staa; J-Y Reginster
Journal:  Osteoporos Int       Date:  2008-07-05       Impact factor: 4.507

6.  Bone complications in patients with Cushing's syndrome: looking for clinical, biochemical, and genetic determinants.

Authors:  L Trementino; G Appolloni; L Ceccoli; G Marcelli; C Concettoni; M Boscaro; G Arnaldi
Journal:  Osteoporos Int       Date:  2013-10-15       Impact factor: 4.507

7.  Clinical analysis of chinese patients with rheumatoid arthritis treated with leflunomide and methotrexate combined with different dosages of glucocorticoid.

Authors:  Cong-Zhu Ding; Yao Yao; Xue-Bing Feng; Yun Fang; Cheng Zhao; Yue Wang
Journal:  Curr Ther Res Clin Exp       Date:  2012-09

Review 8.  The role of autophagy in steroid necrosis of the femoral head: a comprehensive research review.

Authors:  Pan Luo; Fuqiang Gao; Jun Han; Wei Sun; Zirong Li
Journal:  Int Orthop       Date:  2018-05-25       Impact factor: 3.075

9.  The glucocorticoid receptor in osteoprogenitors regulates bone mass and marrow fat.

Authors:  Jessica L Pierce; Ke-Hong Ding; Jianrui Xu; Anuj K Sharma; Kanglun Yu; Natalia Del Mazo Arbona; Zuleika Rodriguez-Santos; Paul Bernard; Wendy B Bollag; Maribeth H Johnson; Mark W Hamrick; Dana L Begun; Xing M Shi; Carlos M Isales; Meghan E McGee-Lawrence
Journal:  J Endocrinol       Date:  2019-07-01       Impact factor: 4.286

10.  Bone density, structure, and strength in juvenile idiopathic arthritis: importance of disease severity and muscle deficits.

Authors:  Jon M Burnham; Justine Shults; Sarah E Dubner; Harjeet Sembhi; Babette S Zemel; Mary B Leonard
Journal:  Arthritis Rheum       Date:  2008-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.